MARSHALL WACE, LLP - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 70 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$184,000
-49.2%
425,4970.0%0.00%
-100.0%
Q2 2022$362,000
-85.4%
425,497
-5.8%
0.00%
-80.0%
Q1 2022$2,487,000
+2140.5%
451,505
+3765.3%
0.01%
+400.0%
Q4 2019$111,000
-96.1%
11,681
-92.7%
0.00%
-92.9%
Q1 2019$2,878,000159,0460.01%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Abbot Financial Management, Inc. 1,411,775$25,243,00011.48%
Flagship Pioneering Inc. 38,506,526$688,497,0007.21%
Artal Group S.A. 4,155,625$74,303,0001.66%
HARBOURVEST PARTNERS LLC 986,878$17,645,0001.66%
Nan Fung Group Holdings Ltd 56,768$1,015,0000.32%
Lombard Odier Asset Management (Switzerland) SA 245,013$4,381,0000.27%
Bellwether Advisors, LLC 29,383$525,0000.18%
PDT Partners, LLC 65,991$1,180,0000.08%
Virtus ETF Advisers LLC 7,478$134,0000.06%
HITE Hedge Asset Management LLC 24,911$445,0000.06%
View complete list of RUBIUS THERAPEUTICS INC shareholders